Quant to Foster Medical Research with Blockchain Innovation

Transformative technology is Quant’s focal point, starving for the qualities it has shared with Cure3, innovation and ambition. The platform supports medical research, envisioning an efficient future for developing programmable digital money.

Quant has emerged as the lead sponsor for the 5th generation of Cure3, a fund-giving program dedicated to advancing research for a Parkinson's cure. This initiative, hosted by Cure Parkinson's Trust, will feature prestigious art to be sold at Bonhams Gallery, London, on 3rd February (Monday).

We're incredibly proud to be supporting the work @CureParkinsonsT is doing to fund research into finding a cure for #ParkinsonsDisease. Funds raised from the Cure3 art sale will enable some of the most promising clinical research and trials today – learn more here:… pic.twitter.com/P72F1d7ews

This degenerative neurological disease affects over 8.5 million people globally, and Quant is honored to support such funding initiatives for today's most sensitive clinical trials. This trailblazing news was unveiled by Quant to the crypto news via its official X account on a social platform.

Quant to Foster Medical Research with Blockchain Innovation

Transformative technology is Quant's focal point, highlighting the qualities shared with Cure3: innovation and ambition. The platform supports medical research, envisioning an efficient future for developing programmable digital money.

Quant also aims for a future where conditional payments cloud enables greater efficiency in clinical trials. Blockchain technology can simplify funding allocation, reducing costs to empower the healthcare sector, further directing donations and resources to where they're needed most.

Fundraising Through Digital Art, NFTs

Cure3 is paving the way for fundraising this year by integrating its sales with digital art. The sale will introduce NFTs (non-fungible tokens) for the second time, alongside traditional artwork. This progression showcases smart money as a powerful tool. An NFT will also be sold during the actual sale, automatically contributing to the Cure3 mission.

This contribution will enable continuous support for Parkinson's research. The integration of blockchain technology with art underscores the enduring ability of digital assets to drive meaningful change beyond financial necessities.

Quant's dedication to fostering innovation for social good is directly highlighted by its involvement in the Cure3 program. The platform endeavors to create a link between traditional and digital finance, setting the stage for a digital future that blends technology with philanthropy.